IV Euro Diabetes, Endocrinology & Metabolic Diseases Conference
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to IV Euro Diabetes, Endocrinology & Metabolic Diseases Conference — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
IV Euro Diabetes, Endocrinology & Metabolic Diseases Conference (EDEM 2026) — Event Research Description
Event: IV Euro Diabetes, Endocrinology and Metabolic Diseases Conference
Dates: September 21–22, 2026
Venue / City / Country: Istanbul, Turkey (Hybrid)
Overview (What the Conference Is and Why It Exists)
The IV Euro Diabetes, Endocrinology & Metabolic Diseases Conference (EDEM 2026) is positioned as an international meeting focused on advancing scientific understanding and practical clinical outcomes in metabolic disorders. Based on the event’s official scope, the conference emphasizes: (1) advancing scientific understanding of metabolic disorders, (2) exploring cutting-edge diagnostic and therapeutic innovations, and (3) facilitating interdisciplinary exchange that supports translational research, clinical management, and patient-centered outcomes.
The program content highlights a broad scientific and clinical spectrum, including metabolic regulation, obesity and weight management, cardiovascular risk, novel therapeutics, and emerging diagnostic technologies. The conference also explicitly bridges clinical, translational, and experimental research to address current challenges and future directions in diabetes and endocrinology.
1️⃣ Who Attends (Buyers / Attendees)
This conference is healthcare and research–centric, so the strongest attendee “buyer-fit” groups are typically medical decision-makers, clinical leadership, clinical operations decision-makers, and research infrastructure stakeholders. From the official “Target Audience” section, the event expects attendance from the following professional categories:
Main attendee groups listed on the official site
- Diabetologists
- Endocrinologists
- Cardiologists
- Bariatric Surgeons
- Nutritionists and Dietitians
- Podiatrists & Physical Therapists
- Clinical Researchers & Epidemiologists
- Physicians and Physician Assistants
- Registered Nurses and Nurse Practitioners
- Internists and Residents
How we interpret “buyer” intent in this context (practical targeting lens)
Even when the event is clinician- and research-heavy, buyers for products/services tied to diabetes/endocrinology often include: clinical leadership, research leads, diabetes program managers, clinical trial administrators, medical affairs leaders, education/KOL engagement teams, and procurement-adjacent stakeholders (e.g., hospital formulary committees and specialty service line administrators) who influence adoption.
Therefore, for “buyer-only” targeting, the best-fit titles often align to medical affairs, clinical research operations, healthcare technology evaluation, diabetes program leadership, and research/clinical trial management rather than only practicing clinicians.
2️⃣ Where the Show Is Happening + Attendee Geographic Origin
Location: Istanbul, Turkey (Hybrid)
The official site provides the event city and country (Istanbul, Turkey) and states that the event is hybrid. It does not provide a detailed breakdown of attendee geographic origin (for example, country-by-country proportions).
What we can reliably state from the official information
- On-site hub: Istanbul, Turkey
- Format: Hybrid (so there may be remote international participation)
- Audience orientation: International platform language is used (leading experts, early-career researchers, and clinical practitioners)
Recommended geographic targeting (provisional)
Because the official site does not enumerate origin shares, we recommend building country targeting around: Europe + MENA + North Africa + nearby international medical networks, then strengthening with hybrid participation signals (registrant diversity is often higher in hybrid editions). We can refine this once we receive your client/product positioning and the buyer industries you want to prioritize.
3️⃣ Audience Reach (Local / National / Global)
The event is described as an international platform and an international conference. It is held in Istanbul (Turkey), but “international platform” positioning typically signals broader than purely local reach.
The official site does not provide hard metrics (e.g., number of countries represented, expected onsite vs. remote attendance, or local/national/global percentages). Therefore, we categorize reach as: International (global relevance, with Istanbul as the primary physical hub).
4️⃣ Sample Buyer Company Names (BUYERS ONLY) + Websites
Below are representative buyer accounts aligned to the conference theme (diabetes, endocrinology, metabolic disease, obesity/weight management, cardiovascular risk, diagnostics, and research enablement). These are buyer-style organizations that commonly sponsor, exhibit, or engage with KOL communities in this therapeutic area. We can further refine/verify buyer fit to your exact client offering once we review your client website.
Sample Buyer List Table (15–20 records)
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Roche Diabetes Care | https://www.roche.com | Medical Affairs Director / Diabetes Therapy Area Lead | Diabetes devices and clinical evidence building align strongly with endocrinology/diabetes conferences and KOL engagement. |
| 2 | Abbott (FreeStyle Libre) | https://www.abbott.com | Global Clinical Affairs Manager / Diabetes Medical Affairs | CGM adoption and clinical validation are highly relevant to diabetes management and translational research themes. |
| 3 | Dexcom | https://www.dexcom.com | Clinical Development Manager / Diabetes Clinical Operations | Continuous glucose monitoring and evidence generation intersect directly with diagnostic/therapeutic innovation discussions. |
| 4 | Sanofi | https://www.sanofi.com | Medical Excellence Lead / Endocrinology Medical Affairs | Major diabetes/endocrinology therapeutic portfolio and conference KOL strategy fit endocrinology-focused events. |
| 5 | Novo Nordisk | https://www.novonordisk.com | Therapeutic Area Head (Diabetes/Obesity) / Medical Affairs Director | Diabetes and obesity/weight management are core areas that match the conference scope and sessions. |
| 6 | Eli Lilly and Company | https://www.lilly.com | Medical Affairs Director (Endocrinology) / Clinical Strategy Lead | Strong diabetes/endocrinology focus; medical affairs teams actively engage with clinician and research audiences. |
| 7 | Merck (MSD) | https://www.merck.com | Medical Director / Metabolic Disease Therapeutic Lead | Metabolic disease and endocrine research engagement align with interdisciplinary diabetes/endocrinology platforms. |
| 8 | Bayer | https://www.bayer.com | Medical Affairs Manager (Cardio-Metabolic) / Evidence Generation Lead | Conference includes cardiovascular risk in metabolic disorders—strong cross-over for cardio-metabolic positioning. |
| 9 | Medtronic (Diabetes) | https://www.medtronic.com | Clinical Program Manager / Diabetes Technology Clinical Affairs | Diabetes technology and clinical program teams align with diagnostic/therapeutic innovation and patient outcomes. |
| 10 | Amgen | https://www.amgen.com | Medical Affairs Lead (Endocrinology/Metabolism) / Scientific Engagement | Metabolic/renal/cardiovascular intersection areas often drive medical education and research collaboration. |
| 11 | AbbVie | https://www.abbvie.com | Therapeutic Area Medical Director / Scientific Partnerships | Strong medical affairs and clinical evidence culture for metabolic disease themes. |
| 12 | IQVIA | https://www.iqvia.com | Healthcare Analytics Director / Clinical Outcomes & Evidence Lead | Supports outcomes research, epidemiology insights, and real-world evidence—directly aligned to clinical researchers. |
| 13 | CRO (e.g., ICON) | https://www.iconplc.com | Clinical Trial Manager / Endocrinology Study Operations | Trials in diabetes/endocrinology drive ongoing demand for study operations and recruitment ecosystems. |
| 14 | CRO (e.g., Syneos Health) | https://www.syneoshealth.com | Clinical Research Director / Medical Affairs & Trial Solutions Lead | Trial solutions and medical strategy teams engage with investigator communities and research priorities. |
| 15 | Teleflex (if diabetes clinical devices) | https://www.teleflex.com | Market Access Manager / Clinical Solutions Director | Specialized medical device companies often pursue hospital/service-line adoption that relates to metabolic comorbidity care. |
| 16 | Medscape/Healthcare Education (publisher) | https://www.webmd.com | Medical Education Partnerships Lead / Scientific Content Manager | Conferences are strong channels for medical education, dissemination, and evidence communications. |
| 17 | Care/Diabetes Management Platforms (digital health) | https://www.healthtap.com | Clinical Partnerships Manager / Diabetes Program Growth Lead | Hybrid conferences accelerate partnerships for patient-centered outcomes and care pathway innovation. |
| 18 | Obesity/Bariatric Care Providers (network) | https://www.isb-turbo.com | Clinical Program Director (Obesity/Weight Management) / Bariatric Service Lead | Bariatric surgeons and weight management topics are explicitly in scope, making clinical program leaders relevant buyers. |
Top 5 best buyer-style samples to prioritize first (starting points):
Roche Diabetes Care, Abbott (FreeStyle Libre), Dexcom, Novo Nordisk, Sanofi.
5️⃣ Job Profiles, Industries & Event Type
Best job profiles to target (Apollo-style intent, adapted to EDEM 2026)
- Medical Affairs Director / Therapeutic Area Medical Director (Diabetes/Endocrinology)
- Clinical Affairs Manager / Clinical Strategy Lead (Diabetes/Metabolic Disease)
- Clinical Research Director / Epidemiology Research Lead
- Clinical Trial Operations Manager (Study Operations / End-to-End Trial Lead)
- Evidence Generation Manager / Real-World Evidence (RWE) Lead
- Market Access & Outcomes Lead (cardio-metabolic outcomes positioning)
- Scientific Partnerships Manager / KOL Engagement Lead
- Diabetes Program Manager / Endocrine Clinic Program Lead
- Nutrition & Obesity Care Program Director / Clinical Dietetics Program Lead
- Bariatric Surgery Program Liaison / Weight Management Clinical Lead
- Registered Nurse/Nurse Practitioner program leads (if targeting clinical education)
- Healthcare Education & Professional Development Managers (if targeting content dissemination)
Event type (based on scope and described activities)
- Healthcare conference
- Diabetes & Endocrinology scientific meeting
- Metabolic disease research platform
- Interdisciplinary clinical + translational research exchange
- Hybrid format (in-person + remote participation)
- Awards for academic excellence (Best Presenter, Innovative Researcher, Best Poster, Best Young Researcher)
Industries to target (using the provided industry list)
Based on the official target audience and scope, the most relevant industries from the provided list are:
- Pharmaceuticals
- Medical Devices
- Health, Wellness & Fitness
- Hospital & Health Care
- Biotechnology
- Research
- Medical Practice
- Marketing & Advertising (only for medical education / scientific communications teams)
- Professional Training & Coaching (only for clinician education, CPD content, or scientific training)
- Program Development (for care pathways and patient-centered outcome program development)
6️⃣ Estimated Attendance (Expected Total Footfall)
The official website content provided does not state an estimated attendance, onsite footfall, or remote viewership numbers. For accuracy, we cannot fill this with assumptions.
Estimated attendance: Not stated on the official page content provided.
7️⃣ Key Focus Areas & Buyer Engagement
The conference scope explicitly emphasizes how diabetes and endocrine/metabolic disorders are understood and managed through both clinical and research lenses. The strongest “buyer engagement” themes are therefore those that align with translational work, diagnostics/therapeutics, and patient-centered outcomes.
Key focus areas (from the official scope)
- Metabolic regulation
- Obesity and weight management
- Cardiovascular risk in metabolic disease
- Novel therapeutics
- Emerging diagnostic technologies
- Diabetes and endocrine pathophysiology
- Translational research and interdisciplinary collaboration
Buyer engagement angles that tend to work for EDEM-style events
- Evidence & outcomes narrative: aligning products/services with patient-centered outcomes and translational relevance.
- Clinical trial & research participation support: connecting with epidemiologists, clinical researchers, and trial operations stakeholders.
- Clinical education and guideline-aligned care pathways: engaging clinician audiences and nurse practitioner/physician assistant decision influencers.
- Comorbidity management messaging: cardiovascular risk cross-over creates a natural audience overlap with cardio-metabolic stakeholders.
The official site also highlights networking and structured programming elements such as keynote sessions, interdisciplinary workshops, special sessions, and one-on-one networking opportunities. That format generally benefits stakeholders who can provide education, evidence, diagnostics, and therapy innovation.
8️⃣ Client Product Fit Requirement (Critical) — Please Share Your Client Website
To produce the “best buyers” list that matches your exact requirement (and to ensure the buyer types we recommend truly align with what your client sells/does), we need to review your client’s product/service positioning on their website.
Please share your client website URL. After we review it, we will:
- Extract the exact buyer personas most likely to attend with purchasing influence
- Prioritize the most relevant industries from the list (Pharmaceuticals, Medical Devices, Research, Hospital & Health Care, etc.) based on your offering
- Update the sample company table into a refined “best buyers to target first” shortlist
- Provide final recommended job titles and seniority bands for outreach
Provisional buyer-fit mapping (until we receive your client website)
- If your client sells diabetes/endocrinology diagnostics devices → prioritize Medical Devices, Hospital & Health Care; target Clinical Affairs and Clinical Research Operations titles.
- If your client is a pharmaceutical / therapeutics company → prioritize Pharmaceuticals; target Medical Affairs, Evidence Generation, and Therapeutic Area Leadership roles.
- If your client provides clinical research services or trial support (CRO/RWE/analytics) → prioritize Research; target Study Operations, Epidemiology, and Real-World Evidence leaders.
- If your client is diabetes digital health / patient management platform → prioritize Hospital & Health Care and Program Development; target Clinical Partnerships and Program Growth leadership.
9️⃣ Final Recommendation (What We Recommend Doing Next)
EDEM 2026 is a strong fit for buyer outreach because it is explicitly structured around: diabetes, endocrinology, metabolic disease mechanisms, translational research, diagnostic/therapeutic innovation, and interdisciplinary clinical exchange—plus a hybrid format that typically supports broader engagement.
Our recommended approach is:
- Confirm your client website so we can align buyer personas precisely to product/service fit.
- Select the best-fit industries from the approved list (most commonly Pharmaceuticals, Medical Devices, Research, Hospital & Health Care).
- Target job titles aligned to clinical evidence, medical affairs, clinical trial operations, and diabetes/endocrine program leadership.
- Use Istanbul as the physical anchor and treat the event as international due to its stated international platform positioning and hybrid delivery.
Next step from us: Once you share the client website, we will deliver an updated “best buyers to target” list and align job titles tightly to your requirement.
Data sheet
| Event Overview | |
| Event Name | IV Euro Diabetes, Endocrinology & Metabolic Diseases Conference |
| Event Date | September 21-22, 2026 |
| Event Status | Upcoming |
| Venue | Holiday Inn Istanbul |
| City | Istanbul |
| State / Region | Istanbul Province |
| Country | Turkey |
| Organizer | Plenareno |
| Official Event Website | diabetic.plenareno.com |
| Event Type | Hybrid international scientific conference |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness |
| Audience Reach | International medical and research audience; hybrid access expands geographic reach |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low to medium. Official site confirms the event format, dates, and audience but does not publish a verified attendance figure. |
| Main Purpose of Event | To advance scientific understanding of diabetes, endocrinology, obesity, and metabolic diseases through research presentations, expert exchange, networking, and awards. |
| About the Event |
|
IV Euro Diabetes, Endocrinology & Metabolic Diseases Conference is a hybrid scientific meeting focused on diabetes, endocrine disorders, obesity, cardiometabolic risk, diagnostic innovation, and therapeutic advances. The official program emphasizes translational research, interdisciplinary exchange, and clinical management, making the conference relevant to physicians, researchers, and allied health professionals working in metabolic health. The event matters because it brings together clinicians, academic researchers, and healthcare decision-makers who influence treatment pathways, research collaborations, institutional purchasing, and professional education. For suppliers serving healthcare, laboratory, diagnostics, digital health, medical education, or clinical research markets, this is a practical B2B opportunity for lead generation, scientific engagement, partnership development, and attendee profiling. |
| 1. Who Attends: Buyers / Attendees | |||
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Hospital and clinic leadership | Hospitals, medical centers, specialty clinics | Clinical service planning, technology evaluation, vendor selection | High-value buyers for diagnostics, devices, software, and education services |
| Endocrinologists and diabetologists | Private practices, hospitals, university clinics | Clinical influencer, protocol adopter, referral source | Influences therapy adoption, diagnostic use, referral patterns, and educational uptake |
| Research institutions and investigators | Universities, research centers, institutes | Study design, grant activity, lab and data tool selection | Relevant for research tools, clinical trial services, lab technologies, and data platforms |
| Nurses, nurse practitioners, physician assistants | Hospitals, outpatient centers, education programs | Operational influence and care pathway execution | Useful audience for workflow tools, training, patient engagement, and clinical devices |
| Nutritionists and dietitians | Hospitals, wellness programs, private practice | Care planning, lifestyle program recommendations, patient adherence support | Relevant for nutrition products, patient education, digital coaching, and monitoring tools |
| Cardiovascular and bariatric specialists | Specialty hospitals, surgical centers, academic departments | Cross-specialty treatment decision maker | Important for obesity, metabolic surgery, and cardiometabolic solution providers |
| Clinical educators and association leaders | Medical associations, societies, education bodies | Conference programming, curriculum, sponsorship influence | Useful for CME, professional training, and knowledge partnerships |
| Industry sponsors and medtech/pharma teams | Diagnostics, devices, pharmaceutical and digital health companies | Commercial engagement, scientific exchange, partnership development | Key for sponsorship, exhibit, and account-based marketing |
| 2. Event Location and Attendee Geographic Origin | |||
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: Istanbul | Strong local and metro-area participation | High | Major hospital systems, universities, and private clinics are likely to be represented |
| Host region: Istanbul Province / Marmara Region | Regional Turkish medical audience | High | Nearby academic hospitals and specialty practices are natural attendees |
| Turkey national reach | Physicians, researchers, and healthcare professionals across Turkey | High | The topic is nationally relevant for diabetes and metabolic disease care |
| Nearby business and medical hubs | Ankara, Izmir, Bursa, Antalya, Adana | Medium to high | Strong domestic pipeline for speaker, delegate, and sponsor engagement |
| International Europe / MENA reach | Clinicians and researchers from Europe, Middle East, North Africa, and neighboring regions | Medium | Hybrid format supports broader participation beyond travel-constrained attendees |
| 3. Audience Reach | ||
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The official site positions the conference as an international platform with hybrid access, attracting a global scientific and clinical audience. |
| 4. Sample Buyer Companies and Websites | |||||
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Gruppo Policlinico di Monza | Hospital group | Listed speaker affiliation; relevant buyer for endocrinology care, diagnostics, and clinical education | gruppopoliclinicodimonza.it | Medical Director, Endocrinology Head, Procurement Manager, Clinical Research Director | Confirmed Speaker Organization |
| MetaFlow | Science / research organization | Listed speaker affiliation; relevant for research collaboration, digital health, and metabolic science tools | metaflow.org | Research Lead, Program Director, Scientific Affairs, Partnerships Director | Confirmed Speaker Organization |
| UKC Sarajevo | University clinical center | Listed speaker affiliation; relevant for hospital procurement, specialty care, and educational partnerships | ukcs.ba | Hospital Administrator, Department Head, Procurement Director, Research Coordinator | Confirmed Speaker Organization |
| Environmental Research Center (CRE) | Research center | Listed speaker affiliation; relevant for research instrumentation, labs, and data services | cre.dz | Director, Principal Investigator, Lab Manager, Partnerships Lead | Confirmed Speaker Organization |
| Acıbadem Healthcare Group | Hospital / healthcare group | Major regional healthcare buyer for diabetes, endocrinology, diagnostics, and digital health solutions | acibadem.com.tr | Procurement Manager, Medical Director, Endocrinology Department Head, Innovation Manager | Strong Market Fit, Attendance Not Confirmed |
| Koç University Hospital | Academic hospital | Research-heavy institution aligned with metabolic disease, clinical trials, and education | kocuHastanesi.org | Chief Medical Officer, Research Director, Department Chair, Procurement Lead | Strong Market Fit, Attendance Not Confirmed |
| Mayo Clinic | Healthcare system | Global reference center for endocrinology, obesity, and metabolic care | mayoclinic.org | Division Chair, Medical Director, Clinical Innovation Lead, Procurement Director | Strong Market Fit, Attendance Not Confirmed |
| Cleveland Clinic | Healthcare system | Strong fit for endocrine care, clinical trials, and patient management solutions | clevelandclinic.org | Endocrinology Chair, Innovation Director, Supply Chain Director, Research Manager | Strong Market Fit, Attendance Not Confirmed |
| Istanbul University-Cerrahpaşa | University / academic medical center | Local academic audience for scientific exchange, abstract submission, and research partnerships | iuc.edu.tr | Professor, Department Chair, Clinical Research Coordinator, Purchasing Manager | Strong Market Fit, Attendance Not Confirmed |
| Hacettepe University Hospitals | University hospital network | High relevance for clinical research, education, and specialty care procurement | hacettepe.edu.tr | Hospital Director, Endocrinologist, Procurement Manager, Research Director | Strong Market Fit, Attendance Not Confirmed |
| Memorial Healthcare Group | Hospital group | Potential buyer for diagnostics, specialist care solutions, and patient management platforms | memorial.com.tr | Procurement Director, Medical Affairs Lead, Department Head, Operations Director | Strong Market Fit, Attendance Not Confirmed |
| Johns Hopkins Medicine | Academic healthcare system | Relevant for advanced research collaboration and clinical innovation outreach | hopkinsmedicine.org | Research Director, Clinical Program Lead, Department Chair, Innovation Manager | Strong Market Fit, Attendance Not Confirmed |
| National and regional diabetes associations | Associations / societies | Conference alignment, speaker pipelines, education and sponsorship pathways | varies by association | Executive Director, Program Manager, Scientific Secretary, Partnerships Director | Strong Market Fit, Attendance Not Confirmed |
| 5. Job Profiles, Industries and Event Type | ||||
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Medical Officer / Medical Director | Clinical leadership | C-level / Executive | Influences institutional standards, service lines, and solution adoption |
| 2 | Head of Endocrinology / Diabetes | Clinical department | Director / Head | Core audience for therapies, diagnostics, and educational content |
| 3 | Procurement Director / Purchasing Manager | Procurement / supply chain | Director / Manager | Evaluates suppliers, service providers, and contract opportunities |
| 4 | Clinical Research Director / Principal Investigator | Research | Director / Senior Researcher | Important for trials, grants, data tools, and lab partnerships |
| 5 | Bariatric Surgery Lead / Surgical Director | Surgery | Lead / Director | Relevant for obesity treatment pathways and procedure-related solutions |
| 6 | Nursing Director / Nurse Practitioner Lead | Nursing / care delivery | Director / Senior Manager | Implements patient care workflows and education programs |
| 7 | Nutrition Services Manager / Dietetics Lead | Nutrition / wellness | Manager / Lead | Supports metabolic care pathways and patient adherence initiatives |
| 8 | Innovation / Digital Health Lead | Innovation / IT | Manager / Director | Relevant for remote monitoring, patient engagement, and data-driven solutions |
| Apollo Industries | |||
|---|---|---|---|
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
| 1 | Hospital & Health Care | Primary attendee base | Hospitals, clinics, and care networks |
| 2 | Medical Practice | Clinician audience | Physician outreach and referrals |
| 3 | Research | Scientific content focus | Studies, labs, and research partnerships |
| 4 | Pharmaceuticals | Therapeutic relevance | Drug awareness, medical affairs, and KOL outreach |
| 5 | Medical Devices | Diagnostics and monitoring fit | CGM, monitors, point-of-care devices |
| 6 | Biotechnology | Translational science | Biomarkers, trials, and innovation |
| 7 | Biotechnology | Research and clinical innovation | Lab and translational platform buyers |
| 8 | Health, Wellness & Fitness | Lifestyle and metabolic management | Weight management and patient engagement |
| 9 | Information Technology & Services | Digital health and data workflows | Software, analytics, interoperability |
| 10 | Government Administration | Public health relevance | Health ministry and public system stakeholders |
| 11 | Education Management | Medical education attendees | Universities, teaching hospitals, CME programs |
| 6. Estimated Attendance | ||||
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Unconfirmed | Organizer website does not publish a verified total attendance figure | Use as a lead-gen event, but do not rely on a published count |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No official exhibitor directory visible in the supplied source text | Scientific conference format suggests limited traditional exhibition activity |
| Buyer count | Not publicly confirmed | Unconfirmed | No verified buyer list published | Likely composed of clinicians, researchers, and institutional decision-makers |
| Speaker count | Partial speaker list shown on site | Confirmed partial | Official website speaker section | Current page shows selected speakers and references prior speaker content |
| Historical attendance | Not publicly confirmed | Unavailable | No reliable prior-year attendance statistic provided in supplied source text | Attendance analysis should be treated as directional only |
| 7. Key Focus Areas and Buyer Engagement | |||
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Diabetes care | Treatment optimization and patient monitoring | Product demos, KOL meetings, and clinical evidence exchange | Therapies, CGM, monitoring, coaching tools |
| Endocrinology diagnostics | Accurate and efficient testing | Clinical problem-solving and reference testing discussions | Lab assays, point-of-care diagnostics, analyzers |
| Obesity and weight management | Integrated treatment support | Education sessions and referral discussions | Programs, devices, digital adherence support |
| Cardiometabolic risk | Integrated care and risk reduction | Cross-specialty collaboration and evidence-based dialogue | Screening tools, digital care pathways, education |
| Translational research | Move research into practice | Abstract networking and investigator outreach | Clinical trial services, research tools, analytics |
| Interdisciplinary education | Professional development and best practice sharing | Workshop sponsorship and CME-related partnerships | Education platforms, training services, content programs |
| Lead Quality Assessment | ||
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The audience includes clinicians, researchers, and institutional decision-makers directly tied to diabetes and metabolic care. |
| Decision-maker availability | High | Department heads, hospital leaders, and researchers are likely to attend or participate virtually. |
| Data collection potential | Medium | Useful attendee profiling is possible, but current-year participant lists are not publicly confirmed. |
| Apollo targeting potential | Very High | Strong fit for hospital, research, pharma, device, and academic targeting in Apollo. |
| Geographic targeting potential | High | Istanbul and Turkey-based prospects can be targeted alongside broader Europe and MENA markets. |
| Best outreach approach | High-touch, research-led | Use scientific relevance, product evidence, and relationship-based outreach rather than generic sales messaging. |
| Overall lead quality | High | A strong event for healthcare, life sciences, and clinical education lead generation. |
| Best use case | Attendee list building and account-based outreach | Best suited for targeting hospitals, clinics, researchers, and supplier-side healthcare stakeholders. |
| Limitations / risks | Moderate | No verified attendance count or current-year attendee directory is publicly confirmed in the supplied source text. |
| Apollo.io Targeting Recommendation | ||
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Practice; Pharmaceuticals; Medical Devices; Biotechnology; Research; Education Management; Government Administration; Health, Wellness & Fitness; Information Technology & Services | Capture the most relevant scientific, clinical, and institutional buyers |
| Departments | Medical Affairs; Clinical Operations; Research; Procurement; Supply Chain; Innovation; IT; Education; Partnerships | Reach both decision-makers and operational influencers |
| Seniority | Manager; Director; VP; CXO; Owner; Partner; Head | Prioritize buying authority and budget influence |
| Job titles | Medical Director; Endocrinologist; Head of Diabetes; Procurement Director; Research Director; Clinical Research Manager; Lab Manager; Innovation Director; Supply Chain Director; Partnerships Director | Target the people most likely to respond to scientific and commercial outreach |
| Geography | Turkey; Istanbul; Europe; Middle East; North Africa | Align with the event’s core geography and hybrid international reach |
| Employee size | 51-200; 201-500; 501-1,000; 1,001-5,000; 5,001+ | Balance specialist practices with larger hospital systems and academic centers |
| Keywords | diabetes, endocrinology, metabolic disease, obesity, cardiometabolic, clinical research, patient care, hospital procurement, medical affairs, digital health | Improve relevance scoring and message personalization |
| Company type | Hospital, clinic, university, research institute, pharma, medtech | Focus on entities with clinical and scientific buying intent |
Suggested Apollo Search Logic: Combine industry filters for Hospital & Health Care, Medical Practice, Pharmaceuticals, Medical Devices, Biotechnology, and Research with seniority filters such as Director, VP, Head, and C-level. Add keywords like “diabetes,” “endocrinology,” “metabolic disease,” “obesity,” “clinical research,” and “medical affairs” to refine results. For institutional outreach, prioritize organizations in Turkey, Europe, and MENA with hospital, research, or academic medical profiles.
| Best Buyer Targets for Client | |||||||
| Client-product fit summary: This event is best suited for solutions serving hospitals, clinics, academic medicine, diagnostics, research, digital health, medical devices, pharmaceuticals, and clinical education. The strongest buyer prospects are institutions and leaders responsible for endocrinology care, metabolic disease management, procurement, research, and innovation. | |||||||
| Rank | Buyer Company / Organization | Buyer Type | Why It Fits Client Product | Recommended Job Titles | Apollo Industry | Website | Priority Level |
|---|---|---|---|---|---|---|---|
| 1 | Acıbadem Healthcare Group | Hospital group | Large clinical network with relevant specialty and procurement needs | Procurement Director; Medical Director; Endocrinology Head | Hospital & Health Care | acibadem.com.tr | High |
| 2 | Koç University Hospital | Academic hospital | Research-driven environment suited for clinical and diagnostic solutions | Research Director; Department Chair; Procurement Lead | Hospital & Health Care | kocuniversitesi.org | High |
| 3 | Istanbul University-Cerrahpaşa | University / academic medical center | Local academic medical buyer for education, research, and equipment | Professor; Clinical Research Coordinator; Purchasing Manager | Education Management | iuc.edu.tr | High |
| 4 | Hacettepe University Hospitals | University hospital network | Strong fit for scientific exchange and institutional procurement | Hospital Director; Endocrinologist; Research Director | Hospital & Health Care | hacettepe.edu.tr | High |
| 5 | Memorial Healthcare Group | Hospital group | Potential buyer for patient care, diagnostics, and digital health | Procurement Director; Medical Affairs Lead; Operations Director | Hospital & Health Care | memorial.com.tr | High |
| 6 | Mayo Clinic | Healthcare system | Global endocrine reference center and ideal research/innovation target | Division Chair; Innovation Lead; Procurement Director | Hospital & Health Care | mayoclinic.org | Medium |
| 7 | Cleveland Clinic | Healthcare system | Strong fit for clinical education, trials, and specialty solutions | Endocrinology Chair; Research Manager; Supply Chain Director | Hospital & Health Care | clevelandclinic.org | Medium |
| 8 | Johns Hopkins Medicine | Academic healthcare system | High-value target for research collaboration and evidence-based solutions | Research Director; Clinical Program Lead; Department Chair | Hospital & Health Care | hopkinsmedicine.org | Medium |
| 9 | International Diabetes Federation | Association | Highly relevant for networking, education, and partnership opportunities | Executive Director; Partnerships Director; Program Manager | Nonprofit Organization Management | idf.org | Medium |
| 10 | Major pharmaceutical and medtech companies | Supplier-side buyer / sponsor | Medical affairs and commercial teams will value KOL access and scientific visibility | Medical Affairs Director; Brand Manager; Partnerships Director | Pharmaceuticals; Medical Devices | varies by company | Medium |
| Client Fit Review Required |
| Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event. |
| Sources & Verification Notes | |||
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| diabetic.plenareno.com | Official organizer website | Event name, hybrid format, dates, city, country, scope, target audience, deadlines, and partial speaker information | High |
| Official event page content supplied by user | Primary source text extract | Confirmed conference positioning, thematic coverage, audience composition, and agenda positioning | High |
| International Diabetes Federation | Association website | Used as a relevant industry association reference for targeting and prospecting context | Medium |
| Mayo Clinic | Institution website | Used as a prospecting target example for endocrine and metabolic care relevance | Medium |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to IV Euro Diabetes, Endocrinology & Metabolic Diseases Conference — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.